Find Cifenline manufacturers, exporters & distributors on PharmaCompass

Cifenline

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 1 USDMF, 3 JDMF, 1 NDC API, 1 Listed Suppliers

4 API Suppliers
1 USDMF
3 JDMF
1 NDC API
1 Listed Suppliers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 100678-32-8, Cifenline succinate, Cipralan, Cibenol, Cifenline succinate [usan], 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1h-imidazole succinate

Molecular Formula

C₂₂H₂₄N₂O₄

Molecular Weight

380.4 g/mol

InChI Key

XFUIOIWYMHEPIE-UHFFFAOYSA-N

FDA UNII

38G16RWJ37

1 2D Structure

Cifenline

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

butanedioic acid;2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole

2.1.2 InChI

InChI=1S/C18H18N2.C4H6O4/c1-3-7-14(8-4-1)18(15-9-5-2-6-10-15)13-16(18)17-19-11-12-20-17;5-3(6)1-2-4(7)8/h1-10,16H,11-13H2,(H,19,20);1-2H2,(H,5,6)(H,7,8)

2.1.3 InChI Key

XFUIOIWYMHEPIE-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1CN=C(N1)C2CC2(C3=CC=CC=C3)C4=CC=CC=C4.C(CC(=O)O)C(=O)O

2.2 Other Identifiers

2.2.1 UNII

38G16RWJ37

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 2-(2,2-diphenylcyclopropyl)-2-imidazoline

2. Cibenzoline

3. Cifenline

4. Cifenline Succinate

5. Cifenline, (s)-isomer

6. Cipralan

7. Exacor

2.3.2 Depositor-Supplied Synonyms

1. 100678-32-8

2. Cifenline Succinate

3. Cipralan

4. Cibenol

5. Cifenline Succinate [usan]

6. 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1h-imidazole Succinate

7. 85589-37-3

8. Cibenzoline Succinate [jan]

9. Ro 22-7796/001

10. 38g16rwj37

11. Butanedioic Acid, Compd. With 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1h-imidazole (1:1)

12. Cipralan; Exacor; Ro 22-7796/001

13. Ritmalan

14. Exacor

15. Butanedioic Acid;2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1h-imidazole

16. Cifenline Succinate (usan)

17. Cibenzoline Succinate (1:1)

18. Ncgc00162222-01

19. Ro-227796001

20. Unii-38g16rwj37

21. Cipralan (tn)

22. Cibenol (tn)

23. (+-)-2-(2,2-diphenylcyclopropyl)-2-imidazoline Succinate (1:1)

24. 4,5-dihydro-2-(2,2-diphenylcyclopropyl)-1h-imidazole Succinate

25. 1h-imidazole, 4,5-dihydro-2-(2,2-diphenylcyclopropyl)-, Succinate

26. 1h-imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-, (+-)-, Butanedioate (1:1)

27. Butanedioic Acid, Compd. With 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1h-imidazole

28. Dsstox_cid_27797

29. Dsstox_rid_82569

30. Dsstox_gsid_47820

31. Schembl121044

32. Cibenzoline Succinate (jp17)

33. Chembl3189111

34. Cifenline Succinate [mi]

35. Dtxsid0047820

36. Chebi:31396

37. Hms3262i07

38. Tox21_112004

39. Tox21_500683

40. Akos016339647

41. Cibenzoline Succinate [who-dd]

42. Ccg-221987

43. Ks-1343

44. Lp00683

45. Ro-227796

46. Ncgc00261368-01

47. Up-33901

48. Cas-100678-32-8

49. Ft-0623817

50. Cibenzoline Succinate, >=97% (nmr), Solid

51. D01455

52. 678c328

53. Ro-22-7796/001

54. J-000196

55. Q27256782

56. 1-[2-(z)-methoxyimino-2-(2-aminothiazol-4-yl)acetoxy]benzotrizole

57. (+/-)-2-(2,2-diphenylcyclopropyl)-2-imidazoline Succinate (1:1)

58. 1h-imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-, (+/-)-, Butanedioate (1:1)

2.4 Create Date

2005-06-24

3 Chemical and Physical Properties

Molecular Formula	C₂₂H₂₄N₂O₄
Molecular Weight	380.4 g/mol
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	6
Exact Mass	380.17360725 g/mol
Monoisotopic Mass	380.17360725 g/mol
Topological Polar Surface Area	99 Å²
Heavy Atom Count	28
Formal Charge	0
Complexity	450
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)

API SUPPLIERS